Cutler Group’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$2K Buy
+600
New +$41.2K ﹤0.01% 1928
2022
Q4
Sell
-3,000
Closed -$1K 5667
2022
Q3
$1K Sell
3,000
-1,700
-36% -$88.8K ﹤0.01% 4755
2022
Q2
$23K Sell
4,700
-5,200
-53% -$295K ﹤0.01% 2571
2022
Q1
$59K Buy
9,900
+6,100
+161% +$317K 0.01% 2121
2021
Q4
$39K Buy
3,800
+2,800
+280% +$118K ﹤0.01% 2604
2021
Q3
$8K Sell
1,000
-9,100
-90% -$316K ﹤0.01% 4160
2021
Q2
$22K Buy
10,100
+9,000
+818% +$333K ﹤0.01% 3251
2021
Q1
$8K Sell
1,100
-2,000
-65% -$69.4K ﹤0.01% 4040
2020
Q4
$34K Sell
3,100
-1,900
-38% -$49.9K ﹤0.01% 2286
2020
Q3
$25K Sell
5,000
-4,000
-44% -$91.3K ﹤0.01% 2294
2020
Q2
$46K Buy
9,000
+7,700
+592% +$156K ﹤0.01% 1808
2020
Q1
$6K Sell
1,300
-39,600
-97% -$860K ﹤0.01% 3029
2019
Q4
$378K Buy
40,900
+28,300
+225% +$340K 0.03% 548
2019
Q3
$4K Buy
12,600
+5,500
+77% +$52.7K ﹤0.01% 3229
2019
Q2
$18K Buy
7,100
+5,000
+238% +$64.1K ﹤0.01% 2301
2019
Q1
$1K Sell
2,100
-19,100
-90% -$244K ﹤0.01% 3851
2018
Q4
$5K Buy
21,200
+9,600
+83% +$155K ﹤0.01% 2959
2018
Q3
$50K Buy
11,600
+600
+5% +$12.5K ﹤0.01% 1617
2018
Q2
$30K Buy
11,000
+1,800
+20% +$36.5K ﹤0.01% 1935
2018
Q1
$48K Sell
9,200
-3,200
-26% -$62.3K 0.01% 1697
2017
Q4
$23K Sell
12,400
-41,100
-77% -$635K ﹤0.01% 2460
2017
Q3
$100K Buy
53,500
+34,000
+174% +$499K ﹤0.01% 1678
2017
Q2
$38K Sell
19,500
-92,700
-83% -$1.07M ﹤0.01% 2778
2017
Q1
$150K Buy
112,200
+103,000
+1,120% +$1.49M 0.01% 1404
2016
Q4
$19K Sell
9,200
-149,400
-94% -$2.11M ﹤0.01% 3527
2016
Q3
$29K Buy
158,600
+99,400
+168% +$4.02M ﹤0.01% 3059
2016
Q2
$134K Buy
59,200
+34,500
+140% +$1.24M 0.01% 1443
2016
Q1
$14K Buy
24,700
+10,300
+72% +$343K ﹤0.01% 3707
2015
Q4
$139K Buy
+14,400
New +$726K 0.01% 1487

Other funds holding ITCI